Free equity investment tool of Japanese companies

Financial Indicator Details

Annual

First quarter

Second quarter

Third quarter

Sponsored Link

Related Company

Aderans

FamilyMart

スギホールディングス

シャクリー・グローバル・グループ

ニトリホールディングス

Credit Saison

JIN

Sundrug

GROWELL HOLDINGS

CHIYODA

OK

FIELDS

SHIMAMURA

くらコーポレーション

TOKYO DERICA

EDIUNET Related Ranking

EDIUNET

EDIUNET Credit Rating

EDIUNET Industry Avg

EDIUNET Prefectures

Yuho! Industry

EDIUNET Rating News

Prev « 2024-04 » Next

Mon	Tue	Wed	Thu	Fri	Sat	Sun
1 -	2 -	3 -	4 -	5 -	6 -	7 -
8 -	9 -	10 -	11 -	12 -	13 -	14 -
15 -	16 -	17 -	18 -	19 -	20 -	21 -
22 -	23 -	24 -	25 -	26 -	27 -	28 -
29 -	30 -

[Update list]

1/28 Retail Trade (CAWACHI:A etc...

1/27 Banks (The Awa Bank:BBB→A)

1/23 Chemicals (Milbon:AA→AAA)

1/21 Glass & Ceramics Products (..

1/21 Machinery (TSUDAKOMA:C)

1/21 Other Services (Netindex.:CC)

1/20 Other Products (Kurogane Kos..

1/20 Wholesale Trade (リーバイ・..

1/20 Other Services (川崎地質:BB→..

1/17 Chemicals (Kawaguchi Chemica..

 RSS

 Company RSS

 Daily RSS

Sponsored Link

Recently Download Chart

KIKUSUI ELECTRONICS etc.

KIKUSUI ELECTRONICS etc.

SANKEI CHEMICAL

PIONEER etc.

PIONEER

Financial Indicator Details: Sundrug (Annual )

Two or more periods are displayed by each of financial indicator collectively.Two or more companies can be compared and financial indicator data can also be downloaded.

【Analysis Menu】 Outline Statement Rating Indicator Download

Sponsored Link

*Free Download Financial Indicator data

Indicator Summary: Sundrug (Annual )

Consolidated :Indicator Consolidated | Non-Consolidated

Profitability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Net profit margin (Industry Average)	3.83% (-0.49%)	3.32% (-0.35%)	3.01% (0.23%)	3.25% (0.97%)	3.67% (1.19%)
C/F margin (Industry Average)	4.39% (3.08%)	3.43% (4.28%)	5.00% (4.21%)	4.40% (5.17%)	5.65% (4.23%)
ROA (Industry Average)	9.00% (0.52%)	7.24% (0.13%)	7.76% (0.97%)	8.19% (0.73%)	8.89% (1.98%)
ROE (Industry Average)	14.43% (-3.32%)	13.61% (-9.27%)	13.89% (-4.25%)	14.20% (4.95%)	14.84% (3.95%)
Growth	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Equity growth (Industry Average)	- (-)	12.25% (5.78%)	12.83% (-3.81%)	13.18% (2.74%)	13.78% (7.73%)
Sales growth (Industry Average)	- (-)	22.18% (-2.32%)	26.94% (1.09%)	7.25% (0.45%)	5.31% (4.65%)
Net profit growth (Industry Average)	- (-)	5.85% (9.35%)	15.15% (-17.12%)	15.72% (-35.52%)	18.87% (-6.96%)
Operating C/F growth (Industry Average)	- (-)	-4.60% (235.79%)	84.97% (193.77%)	-5.67% (742.79%)	35.38% (38.41%)
Stability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Capital adequacy (Industry Average)	62.39% (42.57%)	53.23% (41.58%)	55.88% (41.43%)	57.72% (41.29%)	59.95% (45.41%)
Liquidity ratio (Industry Average)	176.27% (154.66%)	144.87% (126.76%)	152.07% (130.88%)	155.92% (135.64%)	164.12% (146.66%)
C/F ratio current liabilities (Industry Average)	345.09% (1,268.53%)	514.20% (1,032.03%)	294.20% (-860.62%)	346.40% (535.95%)	268.58% (1,140.97%)
Quick ratio (Industry Average)	80.91% (82.69%)	41.68% (70.32%)	49.41% (72.92%)	50.84% (76.50%)	58.38% (84.13%)
Turnover	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Receivables turnover (Industry Average)	13.18day (38.31day)	10.29day (27.53day)	7.22day (33.86day)	6.15day (27.90day)	6.19day (28.23day)
Inventory turnover (Industry Average)	0.07day (21.56day)	0.08day (17.98day)	0.06day (17.78day)	0.05day (18.72day)	0.04day (18.40day)
Payable turnover (Industry Average)	41.69day (29.63day)	45.90day (29.78day)	37.13day (29.67day)	37.19day (30.91day)	39.84day (29.78day)
Working capita turnover (Industry Average)	-28.42day (30.24day)	-35.52day (15.74day)	-29.83day (21.97day)	-30.98day (15.72day)	-33.60day (16.85day)
Stock etc.	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Market Value growth (Industry Average)	- (-)	47.80% (24.39%)	6.62% (14.29%)	8.15% (11.37%)	63.08% (42.65%)
Dividend Yield (Industry Average)	1.74% (2.51%)	1.26% (2.04%)	1.22% (1.92%)	1.31% (1.79%)	0.98% (1.53%)
PER (Industry Average)	11.31% (15.70%)	15.79% (12.76%)	14.62% (8.34%)	13.66% (17.32%)	18.75% (24.91%)
PBR (Industry Average)	1.63% (1.21%)	2.15% (1.82%)	2.03% (1.20%)	1.94% (1.19%)	2.78% (1.75%)
PCFR (Industry Average)	9.86% (4.49%)	15.28% (13.23%)	8.80% (-41.35%)	10.10% (2.37%)	12.16% (14.58%)
PSR (Industry Average)	0.43% (0.31%)	0.52% (0.33%)	0.44% (0.35%)	0.44% (0.36%)	0.68% (0.50%)

Non-Consolidated :Indicator Consolidated | Non-Consolidated

Profitability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Net profit margin (Industry Average)	3.85% (-0.34%)	3.73% (-9.80%)	3.50% (-1.29%)	3.67% (-9.88%)	4.19% (-90.30%)
C/F margin (Industry Average)	- (1.28%)	- (-1.69%)	- (0.77%)	- (1.28%)	- (1.07%)
ROA (Industry Average)	8.90% (0.35%)	8.00% (-0.25%)	7.68% (0.08%)	8.03% (0.60%)	8.66% (2.36%)
ROE (Industry Average)	14.18% (0.45%)	13.12% (-9.00%)	12.39% (-10.38%)	12.60% (6.99%)	13.34% (4.79%)
Growth	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Equity growth (Industry Average)	- (-)	11.58% (4.71%)	10.89% (2.59%)	11.03% (2.66%)	11.66% (21.09%)
Sales growth (Industry Average)	- (-)	6.50% (13.25%)	11.71% (15.91%)	7.80% (2.28%)	3.54% (6.18%)
Net profit growth (Industry Average)	- (-)	3.22% (141.01%)	4.75% (145.89%)	12.93% (-210.50%)	18.18% (-32.92%)
Operating C/F growth (Industry Average)	- (-)	- (118.59%)	- (278.88%)	- (-3.15%)	- (52.98%)
Stability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Capital adequacy (Industry Average)	62.80% (50.65%)	60.99% (47.50%)	61.95% (46.63%)	63.75% (46.69%)	64.91% (48.72%)
Liquidity ratio (Industry Average)	176.64% (211.27%)	150.20% (177.93%)	159.51% (184.56%)	170.14% (172.41%)	178.85% (129.95%)
C/F ratio current liabilities (Industry Average)	- (203.50%)	- (-174.55%)	- (431.18%)	- (71.20%)	- (236.77%)
Quick ratio (Industry Average)	80.07% (112.52%)	45.20% (94.42%)	58.55% (96.78%)	70.64% (94.12%)	78.93% (71.55%)
Turnover	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Receivables turnover (Industry Average)	12.73day (33.49day)	14.06day (104.24day)	14.99day (29.52day)	15.53day (22.25day)	16.31day (17.27day)
Inventory turnover (Industry Average)	0.07day (14.68day)	0.10day (11.65day)	0.08day (11.24day)	0.06day (10.05day)	0.06day (7.29day)
Payable turnover (Industry Average)	41.80day (31.82day)	38.90day (53.80day)	38.96day (28.82day)	39.82day (26.69day)	43.54day (21.01day)
Working capita turnover (Industry Average)	-28.99day (16.35day)	-24.73day (62.10day)	-23.89day (11.93day)	-24.22day (5.62day)	-27.16day (3.55day)
Stock etc.	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Market Value growth (Industry Average)	- (-)	47.80% (19.42%)	6.62% (13.51%)	8.15% (12.00%)	63.08% (44.49%)
Dividend Yield (Industry Average)	- (0.53%)	- (0.42%)	- (0.34%)	- (0.31%)	- (0.24%)
PER (Industry Average)	11.50% (3.20%)	16.47% (59.89%)	16.77% (-14.95%)	16.06% (23.19%)	22.16% (-44.40%)
PBR (Industry Average)	1.63% (1.21%)	2.16% (1.34%)	2.07% (1.37%)	2.02% (1.28%)	2.95% (1.86%)
PCFR (Industry Average)	- (4.15%)	- (1.09%)	- (2.97%)	- (1.69%)	- (2.73%)
PSR (Industry Average)	0.44% (4.13%)	0.61% (2.68%)	0.58% (2.77%)	0.59% (2.47%)	0.92% (3.27%)

Financial Indicator Details: Sundrug

Consolidated :Indicator Consolidated | Non-Consolidated

Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Profitability
Net profit margin	3.83%	3.32%	3.01%	3.25%	3.67%
C/F margin	4.39%	3.43%	5.00%	4.40%	5.65%
ROA	9.00%	7.24%	7.76%	8.19%	8.89%
ROE	14.43%	13.61%	13.89%	14.20%	14.84%
Recurring margin	6.50%	5.80%	5.49%	5.89%	6.20%
EBIT margin	6.34%	5.72%	5.21%	5.78%	6.11%
EBITDA margin	7.38%	6.83%	6.37%	7.05%	7.42%
NOPAT margin	3.80%	3.43%	3.12%	3.47%	3.67%
Sales SG rates	76.43%	76.84%	77.31%	76.76%	76.30%
Sales SG&A rates	17.17%	17.52%	17.34%	17.48%	17.62%
Sales R&D expenses rates	-	-	-	-	-
Sales depreciation rates	1.04%	1.10%	1.16%	1.27%	1.30%
Capital expenditures net sales ratio	-0.84%	-1.26%	-1.42%	-1.77%	-2.12%
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Growth
Growth rate of cash	-	-35.99%	48.00%	22.83%	24.58%
Equity growth	-	12.25%	12.83%	13.18%	13.78%
Total assets growth	-	31.57%	7.49%	9.58%	9.54%
Sales growth	-	22.18%	26.94%	7.25%	5.31%
Net profit growth	-	5.85%	15.15%	15.72%	18.87%
Operating C/F growth	-	-4.60%	84.97%	-5.67%	35.38%
Recurring profit growth	-	8.97%	20.11%	15.13%	10.92%
EBIT growth	-	10.31%	15.63%	18.97%	11.39%
EBITDA growth	-	13.02%	18.46%	18.65%	10.78%
NOPAT growth	-	10.31%	15.63%	18.97%	11.39%
Operating expenses growth	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Stability
Capital adequacy	62.39%	53.23%	55.88%	57.72%	59.95%
Liquidity ratio	176.27%	144.87%	152.07%	155.92%	164.12%
C/F ratio current liabilities	345.09%	514.20%	294.20%	346.40%	268.58%
Quick ratio	80.91%	41.68%	49.41%	50.84%	58.38%
Fixed ratio	23.51%	39.18%	38.12%	36.97%	36.64%
D/E ratio	-	15.69%	9.54%	5.73%	1.36%
Loan to Value Ratio	-	8.35%	5.33%	3.31%	0.81%
Business investment C/F ratio	-19.16%	-36.79%	-28.43%	-40.36%	-37.49%
Liabilities with interest growth	-	-	-31.34%	-31.95%	-72.96%
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Turnover
Cash turnover	31.63day	16.57day	19.32day	22.13day	26.17day
Receivables turnover	13.18day	10.29day	7.22day	6.15day	6.19day
Inventory turnover	0.07day	0.08day	0.06day	0.05day	0.04day
Fixed assets turnover	22.80day	34.90day	30.19day	30.89day	33.08day
Total asset turnover	155.39day	167.33day	141.69day	144.76day	150.58day
Payable turnover	41.69day	45.90day	37.13day	37.19day	39.84day
Capital turnover	6.17day	5.05day	3.97day	3.70day	3.52day
Equity turnover	96.95day	89.08day	79.18day	83.56day	90.28day
Working capita turnover	-28.42day	-35.52day	-29.83day	-30.98day	-33.60day
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Balance sheet
Cash etc.	¥ 20 B	¥ 12 B	¥ 19 B	¥ 23 B	¥ 29 B
Accounts receivable-trade	¥ 8 B	¥ 8 B	¥ 7 B	¥ 6 B	¥ 6 B
Other Current Assets	¥ 42 B	¥ 59 B	¥ 61 B	¥ 68 B	¥ 72 B
Current Assets	¥ 62 B	¥ 72 B	¥ 80 B	¥ 91 B	¥ 101 B
Tangible Assets	¥ 14 B	¥ 27 B	¥ 29 B	¥ 32 B	¥ 36 B
Intangible Assets	¥ 4 B	¥ 6 B	¥ 5 B	¥ 5 B	¥ 4 B
Investment etc.	¥ 17 B	¥ 23 B	¥ 23 B	¥ 23 B	¥ 24 B
Total Assets	¥ 98 B	¥ 130 B	¥ 140 B	¥ 153 B	¥ 168 B
Current Liabilities	¥ 35 B	¥ 50 B	¥ 53 B	¥ 58 B	¥ 61 B
Fixed Liabilities	¥ 1 B	¥ 10 B	¥ 8 B	¥ 5 B	¥ 5 B
Liabilities with interest	-	¥ 10 B	¥ 7 B	¥ 5 B	¥ 1 B
Net Assets	¥ 61 B	¥ 69 B	¥ 78 B	¥ 88 B	¥ 100 B
Capital stock	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B
Capital surplus etc.	¥ 57 B	¥ 65 B	¥ 74 B	¥ 84 B	¥ 96 B
Liabilities and net assets	¥ 98 B	¥ 130 B	¥ 140 B	¥ 153 B	¥ 168 B
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Income statement
Sales	¥ 232 B	¥ 284 B	¥ 360 B	¥ 386 B	¥ 407 B
Cost of Sales	¥ 177 B	¥ 218 B	¥ 278 B	¥ 296 B	¥ 310 B
Gross profit	¥ 54 B	¥ 65 B	¥ 81 B	¥ 89 B	¥ 96 B
Other income	¥ 419 M	¥ 575 M	¥ 673 M	¥ 676 M	¥ 660 M
SG&A	¥ 39 B	¥ 49 B	¥ 62 B	¥ 67 B	¥ 71 B
Other expenses	¥ 6 B	¥ 7 B	¥ 9 B	¥ 10 B	¥ 10 B
Net income	¥ 8 B	¥ 9 B	¥ 10 B	¥ 12 B	¥ 14 B
Operating income	¥ 14 B	¥ 16 B	¥ 19 B	¥ 22 B	¥ 24 B
Ordinary Income	¥ 15 B	¥ 16 B	¥ 19 B	¥ 22 B	¥ 25 B
EBITDA	¥ 17 B	¥ 19 B	¥ 23 B	¥ 27 B	¥ 30 B
Income before income taxes	¥ 14 B	¥ 16 B	¥ 18 B	¥ 22 B	¥ 25 B
Depreciation	¥ 2 B	¥ 3 B	¥ 4 B	¥ 4 B	¥ 5 B
R&D expenses	-	-	-	-	-
Income taxes	¥ 5 B	¥ 6 B	¥ 7 B	¥ 9 B	¥ 10 B
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Cash flow statement
Operating CF	¥ 10 B	¥ 9 B	¥ 18 B	¥ 17 B	¥ 23 B
Investment CF	¥ -4 B	¥ -12 B	¥ -6 B	¥ -8 B	¥ -10 B
Financial CF	¥ -1 B	¥ -4 B	¥ -5 B	¥ -4 B	¥ -6 B
Foreign Exchange Effects	-	-	-	-	-
Net Change in Cash	¥ 3 B	¥ -7 B	¥ 6 B	¥ 4 B	¥ 5 B
Free CF	¥ 5 B	¥ -3 B	¥ 11 B	¥ 9 B	¥ 12 B
Capital expenditures	¥ -1 B	¥ -3 B	¥ -5 B	¥ -6 B	¥ -8 B
Cash dividends paid	¥ -1 B	¥ -1 B	¥ -1 B	¥ -2 B	¥ -2 B
Repayment loans	-	¥ -20 B	¥ -4 B	¥ -9 B	¥ -13 B
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Shareowners' equity
Issuance of new shares	-	-	-	-	-
Dividends from surplus	¥ -1 B	¥ -1 B	¥ -1 B	¥ -2 B	¥ -2 B
Net income	¥ 8 B	¥ 9 B	¥ 10 B	¥ 12 B	¥ 14 B
Purchase of treasury stock	-	-	-	-	-
Other Change in Stockholders Equity	¥ -2 M	-	¥ -3 M	¥ -1 M	¥ 1 M
Other Change in Net Assets	¥ -38 M	¥ 22 M	¥ -17 M	¥ 7 M	¥ 27 M
Net Change in Net Assets	¥ 7 B	¥ 7 B	¥ 8 B	¥ 10 B	¥ 12 B

Financial Indicator Details: Sundrug

Non-Consolidated :Indicator Consolidated | Non-Consolidated

Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Profitability
Net profit margin	3.85%	3.73%	3.50%	3.67%	4.19%
C/F margin	-	-	-	-	-
ROA	8.90%	8.00%	7.68%	8.03%	8.66%
ROE	14.18%	13.12%	12.39%	12.60%	13.34%
Recurring margin	6.54%	6.42%	6.22%	6.45%	6.91%
EBIT margin	6.37%	6.34%	5.97%	6.37%	6.83%
EBITDA margin	7.40%	7.42%	7.02%	7.42%	7.76%
NOPAT margin	3.82%	3.80%	3.58%	3.82%	4.09%
Sales SG rates	77.34%	76.96%	77.67%	77.61%	77.32%
Sales SG&A rates	17.17%	17.69%	17.03%	16.83%	16.64%
Sales R&D expenses rates	-	-	-	-	-
Sales depreciation rates	1.03%	1.07%	1.04%	1.04%	0.93%
Capital expenditures net sales ratio	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Growth
Growth rate of cash	-	-62.01%	78.61%	45.44%	25.11%
Equity growth	-	11.58%	10.89%	11.03%	11.66%
Total assets growth	-	14.90%	9.16%	7.90%	9.66%
Sales growth	-	6.50%	11.71%	7.80%	3.54%
Net profit growth	-	3.22%	4.75%	12.93%	18.18%
Operating C/F growth	-	-	-	-	-
Recurring profit growth	-	4.60%	8.19%	11.80%	10.88%
EBIT growth	-	6.03%	5.28%	14.97%	10.95%
EBITDA growth	-	6.73%	5.70%	13.90%	8.41%
NOPAT growth	-	6.03%	5.28%	14.97%	10.95%
Operating expenses growth	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Stability
Capital adequacy	62.80%	60.99%	61.95%	63.75%	64.91%
Liquidity ratio	176.64%	150.20%	159.51%	170.14%	178.85%
C/F ratio current liabilities	-	-	-	-	-
Quick ratio	80.07%	45.20%	58.55%	70.64%	78.93%
Fixed ratio	23.12%	21.84%	20.65%	18.67%	17.15%
D/E ratio	-	10.63%	6.09%	2.34%	-
Loan to Value Ratio	-	6.48%	3.77%	1.49%	-
Business investment C/F ratio	-	-	-	-	-
Liabilities with interest growth	-	-	-36.41%	-57.27%	-100.00%
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Turnover
Cash turnover	31.83day	11.35day	18.15day	24.49day	29.59day
Receivables turnover	12.73day	14.06day	14.99day	15.53day	16.31day
Inventory turnover	0.07day	0.10day	0.08day	0.06day	0.06day
Fixed assets turnover	22.95day	22.72day	21.32day	19.85day	19.67day
Total asset turnover	158.06day	170.52day	166.63day	166.79day	176.65day
Payable turnover	41.80day	38.90day	38.96day	39.82day	43.54day
Capital turnover	6.31day	5.92day	5.30day	4.92day	4.75day
Equity turnover	99.27day	104.00day	103.24day	106.33day	114.68day
Working capita turnover	-28.99day	-24.73day	-23.89day	-24.22day	-27.16day
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Balance sheet
Cash etc.	¥ 19 B	¥ 7 B	¥ 13 B	¥ 19 B	¥ 24 B
Accounts receivable-trade	¥ 7 B	¥ 9 B	¥ 11 B	¥ 12 B	¥ 13 B
Other Current Assets	¥ 41 B	¥ 48 B	¥ 53 B	¥ 57 B	¥ 61 B
Current Assets	¥ 61 B	¥ 55 B	¥ 66 B	¥ 76 B	¥ 85 B
Tangible Assets	¥ 14 B	¥ 15 B	¥ 15 B	¥ 15 B	¥ 16 B
Intangible Assets	¥ 4 B	¥ 4 B	¥ 3 B	¥ 3 B	¥ 3 B
Investment etc.	¥ 18 B	¥ 37 B	¥ 36 B	¥ 36 B	¥ 39 B
Total Assets	¥ 98 B	¥ 113 B	¥ 123 B	¥ 133 B	¥ 146 B
Current Liabilities	¥ 34 B	¥ 37 B	¥ 41 B	¥ 45 B	¥ 48 B
Fixed Liabilities	¥ 1 B	¥ 6 B	¥ 5 B	¥ 3 B	¥ 3 B
Liabilities with interest	-	¥ 7 B	¥ 4 B	¥ 1 B	-
Net Assets	¥ 61 B	¥ 68 B	¥ 76 B	¥ 84 B	¥ 94 B
Capital stock	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B
Capital surplus etc.	¥ 57 B	¥ 65 B	¥ 72 B	¥ 80 B	¥ 90 B
Liabilities and net assets	¥ 98 B	¥ 113 B	¥ 123 B	¥ 133 B	¥ 146 B
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Income statement
Sales	¥ 227 B	¥ 241 B	¥ 270 B	¥ 291 B	¥ 301 B
Cost of Sales	¥ 175 B	¥ 186 B	¥ 209 B	¥ 226 B	¥ 233 B
Gross profit	¥ 51 B	¥ 55 B	¥ 60 B	¥ 65 B	¥ 68 B
Other income	¥ 436 M	¥ 508 M	¥ 435 M	¥ 489 M	¥ 435 M
SG&A	¥ 39 B	¥ 42 B	¥ 46 B	¥ 49 B	¥ 50 B
Other expenses	¥ 6 B	¥ 6 B	¥ 7 B	¥ 8 B	¥ 8 B
Net income	¥ 8 B	¥ 9 B	¥ 9 B	¥ 10 B	¥ 12 B
Operating income	¥ 14 B	¥ 15 B	¥ 16 B	¥ 18 B	¥ 20 B
Ordinary Income	¥ 14 B	¥ 15 B	¥ 16 B	¥ 18 B	¥ 20 B
EBITDA	¥ 16 B	¥ 17 B	¥ 18 B	¥ 21 B	¥ 23 B
Income before income taxes	¥ 14 B	¥ 15 B	¥ 16 B	¥ 18 B	¥ 20 B
Depreciation	¥ 2 B	¥ 2 B	¥ 2 B	¥ 3 B	¥ 2 B
R&D expenses	-	-	-	-	-
Income taxes	¥ 5 B	¥ 6 B	¥ 6 B	¥ 7 B	¥ 8 B
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Cash flow statement
Operating CF	-	-	-	-	-
Investment CF	-	-	-	-	-
Financial CF	-	-	-	-	-
Foreign Exchange Effects	-	-	-	-	-
Net Change in Cash	-	-	-	-	-
Free CF	-	-	-	-	-
Capital expenditures	-	-	-	-	-
Cash dividends paid	-	-	-	-	-
Repayment loans	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Shareowners' equity
Issuance of new shares	-	-	-	-	-
Dividends from surplus	¥ -1 B	¥ -1 B	¥ -1 B	¥ -2 B	¥ -2 B
Net income	¥ 8 B	¥ 9 B	¥ 9 B	¥ 10 B	¥ 12 B
Purchase of treasury stock	-	-	-	-	-
Other Change in Stockholders Equity	¥ -2 M	¥ -1 M	¥ -1 M	¥ -1 M	¥ 1 M
Other Change in Net Assets	¥ -38 M	-	¥ -10 M	¥ 5 M	¥ 27 M
Net Change in Net Assets	¥ 6 B	¥ 7 B	¥ 7 B	¥ 8 B	¥ 9 B

Free Download

*Free Download Financial Indicator dataMember limited service.

[Data] Net Profit Margin, Sales Growth, Equity Margin etc., 100 or more kinds of financial indicators. (*Consolidated or Non-Consolidated. two or more terms)

Sponsored Link

Related Information: Sundrug (Annual )

Statement Type

Annual : Sundrug

First quarter : Sundrug

Second quarter : Sundrug

Third quarter : Sundrug

Analysis Menu

Outline : Sundrug

Statement : Sundrug

Rating : Sundrug

Indicator : Sundrug

Download : Sundrug

Industry Comparison Ranking

Retail Trade - EDIUNET Industry Rankings

Retail Trade - EDIUNET Credit Rating

Retail Trade - EDIUNET Industry Avg

Comparison with a neighboring company

Tokyo - EDIUNET Prefectures

Tokyo府中市 - EDIUNET Prefectures

Related company's newest statement

Date	Company	Credit Rating	Date
1/28	CAWACHI	A	2013-12-15 (Q3)
1/28	ハチバン	A	2013-12-20 (Q3)
1/15	SALA	AA→A	2013-11-30
1/15	CAN DO	BB→BBB	2013-11-30
1/15	BIC CAMERA	CCC→BBB	2013-11-30 (Q1)
1/15	Shimachu	AA	2013-11-30 (Q1)
1/15	COSMOS Pharmaceutical	AAA→AA	2013-11-30 (Q2)
1/15	AEON	BBB	2013-11-30 (Q3)
1/15	LIFE	-→AAA	2013-11-30 (Q3)
1/15	The Maruetsu	BBB→A	2013-11-30 (Q3)

EDIUNET Investment News (Retail Trade)

1/28 Retail Trade (CAWACHI:A etc...

1/15 Retail Trade (SALA:AA→A etc...

1/10 Retail Trade (ファーストリテ..

1/9 Retail Trade (The Daiei:C et..

1/7 Retail Trade (CREATE SD HOLD..

1/6 Retail Trade (あみやき亭:AA ..

12/27 Retail Trade (HIMARAYA:CCC→C..

12/26 Retail Trade (J.FRONT RETAIL..

12/25 Retail Trade (PARCO:A etc.2 ..

12/24 Retail Trade (ライトオン:B→C..

Company Information

Ticker	Market	Industry	Month	report	Rating
Sundrug	9989	TSE 1st	Retail Trade	3	Annual	AAA

Related Company

シャクリー・グローバル・グループ (Sales ¥ 30 B)

Circle K Sunkus (Sales ¥ 120 B)

TOKYO DERICA (Sales ¥ 45 B)

FamilyMart (Sales ¥ 229 B)

CHIYODA (Sales ¥ 150 B)

OK (Sales ¥ 250 B)

LIFE (Sales ¥ 505 B)

SHIP HEALTHCARE HOLDINGS (Sales ¥ 224 B)

GROWELL HOLDINGS (Sales ¥ 334 B)

Sundrug (Sales ¥ 407 B)

Maxvalu Tokai (Sales ¥ 164 B)

AOYAMA TRADING (Sales ¥ 212 B)

Lawson (Sales ¥ 294 B)

関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .